{"id":2422,"date":"2019-10-06T01:29:23","date_gmt":"2019-10-05T23:29:23","guid":{"rendered":"https:\/\/idibell.cat\/?page_id=2422"},"modified":"2024-11-21T12:06:59","modified_gmt":"2024-11-21T11:06:59","slug":"breast-cancer","status":"publish","type":"page","link":"https:\/\/idibell.cat\/en\/research\/cancer-area\/molecular-mechanisms-and-experimental-therapy-in-oncology-program-oncobell\/breast-cancer\/","title":{"rendered":"Breast cancer"},"content":{"rendered":"\n

\n\t\tBreast cancer\n\t<\/h1>\n

\n\t\tSummary\n\t<\/h3>\n\t

The Breast cancer research group aims to better understand breast cancer development, the origin of disease subtypes, and disease progression and vulnerabilities. The research projects comprise the major disease subtypes as well as BRCA1\/2-mutant breast cancer. The group also works to develop novel targeted preventive approaches and to improve the quality of life of patients. This is a multidisciplinary team that combines the experience and knowledge of clinical and translational researchers.<\/p>\n

320<\/h2>\n

Publications<\/h2>\n\t\t\t\t\"breast_carcinoma_in_a_lymph_node\"\n\t\t\t\t\tStrategic lines<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t\u2022 HER2-positive breast cancer (S Pern\u00e0s)
\n\u2022 ER-positive breast cancer (M Gil)
\n\u2022 Metastatic breast cancer and quality of life (C Falo)
\n\u2022 Circulating biomarkers (R Villanueva)
\n\u2022 Genetic basis of breast cancer risk and targeted prevention (MA Pujana)
\n\u2022 Therapeutic resistance and cancer progression (various PIs)
\n\u2022 Preclinical development of novel therapies (various PIs)\n\t\t\t\t\tSelected Publications<\/a>\n\t\t\t\t\t\t\t\t\t\t\tExpand<\/i><\/a>\n\t\t\t\t\t